Handelen Fresenius SE & Co KGaA - FRE CFD
Toevoegen aan favorieten- Samenvatting
- Historische gegevens
- Evenementen
- Winst- en verliesrekening
- Balans
- Cash Flow
- Eigendom
Handelsvoorwaarden
| Spread | 0.10 | ||||||||
|
Overnight-tarief longpositie
Long position overnight fee
Ga naar platform | -0.024161% | ||||||||
|
Overnight-tarief shortpositie
Short position overnight fee
Ga naar platform | -0.020283% | ||||||||
| Tijd van overnight-tarief | 22:00 (UTC) | ||||||||
| Min. verhandelde hoeveelheid | 1 | ||||||||
| Valuta | EUR | ||||||||
| Marge | 20% | ||||||||
| Effectenbeurs | Germany | ||||||||
| Handelscommissie | 0% |
*Information provided by Capital.com
Fresenius SE & Co KGaA ESG Risk Ratings
High Medium Low Negligible
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Belangrijkste statistieken
| Prev. Close* | 27.25 |
| Open* | 26.76 |
| 1-Jaarlijkse Verandering* | -26.85% |
| Dagelijks bereik* | 26.66 - 27.12 |
| 52 wekelijks bereik | 19.69-38.11 |
| Weekgemiddelde volume (10 dagen) | 1.22M |
| Gemiddeld volume (3 maanden) | 26.88M |
| Marktkapitalisatie | 15.27B |
| P/E Ratio | 9.40 |
| Uitstaande Aandelen | 563.24M |
| Omzet | 40.16B |
| EPS | 2.88 |
| Dividend (opbrengst %) | 3.39358 |
| Beta | 1.07 |
| Volgende inkomsten datum | Feb 23, 2023 |
Alle gegevens zijn afkomstig van Refinitiv, behalve de gegevens gemarkeerd met een sterretje, die zijn afkomstig van Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Slotkoers | Change | Change (%) | Openingskoers | High | Low |
|---|---|---|---|---|---|---|
| Feb 3, 2023 | 27.01 | 0.15 | 0.56% | 26.86 | 27.14 | 26.62 |
| Feb 2, 2023 | 27.25 | 0.70 | 2.64% | 26.55 | 27.28 | 26.55 |
| Feb 1, 2023 | 26.56 | 0.02 | 0.08% | 26.54 | 26.67 | 26.36 |
| Jan 31, 2023 | 26.48 | -0.16 | -0.60% | 26.64 | 26.68 | 26.33 |
| Jan 30, 2023 | 26.74 | 0.19 | 0.72% | 26.55 | 26.80 | 26.31 |
| Jan 27, 2023 | 26.70 | 0.51 | 1.95% | 26.19 | 26.79 | 26.15 |
| Jan 26, 2023 | 26.30 | -0.38 | -1.42% | 26.68 | 26.80 | 26.11 |
| Jan 25, 2023 | 26.89 | -0.48 | -1.75% | 27.37 | 27.47 | 26.76 |
| Jan 24, 2023 | 27.71 | -0.33 | -1.18% | 28.04 | 28.07 | 27.53 |
| Jan 23, 2023 | 28.12 | -0.33 | -1.16% | 28.45 | 28.47 | 27.84 |
| Jan 20, 2023 | 28.25 | 0.21 | 0.75% | 28.04 | 28.29 | 27.93 |
| Jan 19, 2023 | 27.99 | -0.19 | -0.67% | 28.18 | 28.30 | 27.66 |
| Jan 18, 2023 | 28.34 | -0.24 | -0.84% | 28.58 | 28.71 | 28.15 |
| Jan 17, 2023 | 28.49 | 0.06 | 0.21% | 28.43 | 28.73 | 28.17 |
| Jan 16, 2023 | 28.61 | 0.17 | 0.60% | 28.44 | 28.67 | 28.35 |
| Jan 13, 2023 | 28.25 | 0.04 | 0.14% | 28.21 | 28.48 | 27.97 |
| Jan 12, 2023 | 28.23 | 0.02 | 0.07% | 28.21 | 28.84 | 27.96 |
| Jan 11, 2023 | 27.98 | 0.57 | 2.08% | 27.41 | 28.23 | 27.31 |
| Jan 10, 2023 | 27.49 | -0.55 | -1.96% | 28.04 | 28.12 | 27.35 |
| Jan 9, 2023 | 28.28 | -0.05 | -0.18% | 28.33 | 28.66 | 28.20 |
Fresenius SE & Co KGaA Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Jaarlijks
- Per kwartaal
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Totale inkomsten | 29471 | 33886 | 33530 | 35409 | 36277 | 37520 |
| Inkomsten | 29471 | 33886 | 33530 | 35409 | 36277 | 37520 |
| Kosten van opbrengsten, totaal | 19958 | 23395 | 23696 | 25061 | 25961 | 27209 |
| Brutowinst | 9513 | 10491 | 9834 | 10348 | 10316 | 10311 |
| Totale bedrijfskosten | 25169 | 29297 | 28279 | 30778 | 31892 | 33362 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 4853 | 5554 | 4873 | 5406 | 5430 | 5453 |
| Onderzoek & Ontwikkeling | 486 | 543 | 650 | 603 | 724 | 762 |
| Depreciation / Amortization | 16 | 15 | 16 | 17 | 20 | 22 |
| Ongebruikelijke uitgaven (inkomsten) | 26 | -26 | -802 | -4 | -24 | 21 |
| Other Operating Expenses, Total | -170 | -184 | -154 | -305 | -219 | -105 |
| Bedrijfsresultaat | 4302 | 4589 | 5251 | 4631 | 4385 | 4158 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | -582 | -667 | -587 | -719 | -659 | -506 |
| Netto inkomen voor belastingen | 3720 | 3922 | 4664 | 3912 | 3726 | 3652 |
| Netto inkomen na belastingen | 2676 | 3033 | 3714 | 3029 | 2823 | 2819 |
| Minderheidsbelang | -1116 | -1219 | -1687 | -1146 | -1116 | -1001 |
| Netto inkomen voor extra. Posten | 1560 | 1814 | 2027 | 1883 | 1707 | 1818 |
| Netto inkomen | 1560 | 1814 | 2027 | 1883 | 1707 | 1818 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 1560 | 1814 | 2027 | 1883 | 1707 | 1818 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 1560 | 1814 | 2027 | 1883 | 1707 | 1818 |
| Verwaterd Netto Inkomen | 1560 | 1814 | 2027 | 1883 | 1707 | 1818 |
| Verwaterd Gewogen Gemiddelde Aandelen | 550.085 | 557.507 | 557.305 | 557.417 | 557.744 | 558.156 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 2.83593 | 3.25377 | 3.63715 | 3.37808 | 3.06054 | 3.25715 |
| Dividends per Share - Common Stock Primary Issue | 0.62 | 0.75 | 0.8 | 0.84 | 0.88 | 0.92 |
| Verwaterde Genormaliseerde Winst per Aandeel | 2.95754 | 3.552 | 2.65123 | 3.5531 | 3.34581 | 2.6265 |
| Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
|---|---|---|---|---|---|
| Totale inkomsten | 8984 | 9246 | 9324 | 9966 | 9720 |
| Inkomsten | 8984 | 9246 | 9324 | 9966 | 9720 |
| Kosten van opbrengsten, totaal | 6526 | 6628 | 6801 | 7254 | 7162 |
| Brutowinst | 2458 | 2618 | 2523 | 2712 | 2558 |
| Totale bedrijfskosten | 7978 | 8225 | 8316 | 8843 | 8818 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 1266 | 1400 | 1300 | 1487 | 1488 |
| Onderzoek & Ontwikkeling | 181 | 186 | 198 | 197 | 174 |
| Depreciation / Amortization | 5 | 5 | 6 | 6 | 5 |
| Bedrijfsresultaat | 1006 | 1021 | 1008 | 1123 | 902 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | -137 | -121 | -126 | -122 | -118 |
| Netto inkomen voor belastingen | 869 | 900 | 882 | 1001 | 784 |
| Netto inkomen na belastingen | 671 | 708 | 681 | 759 | 599 |
| Minderheidsbelang | -236 | -237 | -268 | -260 | -186 |
| Netto inkomen voor extra. Posten | 435 | 471 | 413 | 499 | 413 |
| Netto inkomen | 435 | 471 | 413 | 499 | 413 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 435 | 471 | 413 | 499 | 413 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 435 | 471 | 413 | 499 | 413 |
| Verwaterd Netto Inkomen | 435 | 471 | 413 | 499 | 413 |
| Verwaterd Gewogen Gemiddelde Aandelen | 557.649 | 560.714 | 558.108 | 558.487 | 558.502 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 0.78006 | 0.84 | 0.74 | 0.89349 | 0.73948 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0.92 | 0 |
| Verwaterde Genormaliseerde Winst per Aandeel | 0.46297 | 0.59729 | 0.77459 | 0.67626 | 0.53715 |
| Ongebruikelijke uitgaven (inkomsten) | 6 | 11 | 4 | ||
| Other Operating Expenses, Total | -105 | ||||
| Rentekosten (inkomsten) - Operationeel nettobedrijfsresultaat | -11 |
- Jaarlijks
- Per kwartaal
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Totaal vlottende activa | 11744 | 12604 | 14790 | 15264 | 15772 | 17461 |
| Geldmiddelen en kortetermijnbeleggingen | 1769 | 1462 | 2586 | 1543 | 1716 | 931 |
| Cash | 1215 | 956 | 1150 | 1047 | 1071 | |
| Geldmiddelen & Equivalenten | 303 | 497 | 1436 | 496 | 645 | 931 |
| Korte Termijn Investeringen | 251 | 9 | ||||
| Totale Vorderingen, Netto | 6051 | 7206 | 7766 | 8972 | 8695 | 9308 |
| Accounts Receivable - Trade, Net | 5311 | 6288 | 6628 | 7880 | 7411 | 7532 |
| Total Inventory | 3189 | 3252 | 3218 | 3633 | 3945 | 4218 |
| Prepaid Expenses | 113 | 121 | 147 | 273 | 459 | 441 |
| Other Current Assets, Total | 622 | 563 | 1073 | 843 | 957 | 2563 |
| Total Assets | 46697 | 53133 | 56703 | 67006 | 66646 | 71962 |
| Property/Plant/Equipment, Total - Net | 8139 | 9555 | 10366 | 17266 | 17603 | 18583 |
| Property/Plant/Equipment, Total - Gross | 15401 | 17172 | 18881 | 27566 | 29156 | 32271 |
| Accumulated Depreciation, Total | -7262 | -7617 | -8515 | -10300 | -11553 | -13688 |
| Goodwill, Net | 22901 | 25285 | 25713 | 27737 | 26599 | 28943 |
| Intangibles, Net | 1763 | 3172 | 3130 | 3869 | 3736 | 3831 |
| Long Term Investments | 256 | 19 | ||||
| Note Receivable - Long Term | 460 | 555 | 723 | 220 | 132 | |
| Other Long Term Assets, Total | 1434 | 1943 | 1981 | 2650 | 2804 | 3144 |
| Total Current Liabilities | 9079 | 10665 | 13275 | 13884 | 13216 | 15062 |
| Accounts Payable | 1315 | 1688 | 1823 | 1905 | 1816 | 2039 |
| Accrued Expenses | 3030 | 2912 | 3298 | 1056 | 915 | 1150 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 2475 | 245 | 2841 |
| Current Port. of LT Debt/Capital Leases | 2059 | 3017 | 5094 | 3033 | 3425 | 1931 |
| Other Current Liabilities, Total | 2675 | 3048 | 3060 | 5415 | 6815 | 7101 |
| Total Liabilities | 34033 | 39472 | 41292 | 50228 | 49697 | 52964 |
| Total Long Term Debt | 12843 | 16143 | 14040 | 21750 | 22243 | 22383 |
| Long Term Debt | 12697 | 15909 | 13821 | 16104 | 16821 | 16625 |
| Capital Lease Obligations | 146 | 234 | 219 | 5646 | 5422 | 5758 |
| Deferred Income Tax | 935 | 1110 | 1284 | 1418 | 1390 | 1515 |
| Minority Interest | 8185 | 8059 | 9597 | 9802 | 9074 | 10290 |
| Other Liabilities, Total | 2991 | 3495 | 3096 | 3374 | 3774 | 3714 |
| Total Equity | 12664 | 13661 | 15411 | 16778 | 16949 | 18998 |
| Common Stock | 547 | 555 | 556 | 557 | 557 | 558 |
| Retained Earnings (Accumulated Deficit) | 11544 | 13504 | 15185 | 16411 | 17527 | 18886 |
| Other Equity, Total | 573 | -398 | -330 | -190 | -1135 | -446 |
| Total Liabilities & Shareholders’ Equity | 46697 | 53133 | 56703 | 67006 | 66646 | 71962 |
| Total Common Shares Outstanding | 547.208 | 554.71 | 556.225 | 557.38 | 551.853 | 558.502 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Totaal vlottende activa | 16693 | 16901 | 17334 | 17461 | 18002 |
| Geldmiddelen en kortetermijnbeleggingen | 1877 | 2250 | 2413 | 931 | 2077 |
| Geldmiddelen & Equivalenten | 1877 | 2250 | 2413 | 931 | 2077 |
| Totale Vorderingen, Netto | 7776 | 7497 | 7553 | 7192 | 7983 |
| Accounts Receivable - Trade, Net | 7596 | 7369 | 7402 | 7045 | 7794 |
| Total Inventory | 4092 | 4197 | 4257 | 4218 | 4423 |
| Other Current Assets, Total | 2948 | 2957 | 3111 | 5120 | 3519 |
| Total Assets | 68966 | 69655 | 71081 | 71962 | 73114 |
| Property/Plant/Equipment, Total - Net | 17914 | 17940 | 18126 | 18583 | 18643 |
| Goodwill, Net | 27523 | 27675 | 28338 | 28943 | 29373 |
| Intangibles, Net | 3752 | 3754 | 3771 | 3831 | 3836 |
| Other Long Term Assets, Total | 3084 | 3385 | 3512 | 3144 | 3260 |
| Total Current Liabilities | 15947 | 15204 | 15352 | 15062 | 14138 |
| Accounts Payable | 1635 | 1669 | 1649 | 2039 | 1897 |
| Notes Payable/Short Term Debt | 2037 | 2738 | 2472 | 2841 | 2652 |
| Current Port. of LT Debt/Capital Leases | 4079 | 2536 | 2577 | 1931 | 1282 |
| Other Current Liabilities, Total | 8196 | 8261 | 8654 | 8251 | 8307 |
| Total Liabilities | 51159 | 51956 | 52780 | 52964 | 53244 |
| Total Long Term Debt | 20392 | 22015 | 22142 | 22383 | 23277 |
| Long Term Debt | 14812 | 16470 | 16554 | 16625 | 17543 |
| Capital Lease Obligations | 5580 | 5545 | 5588 | 5758 | 5734 |
| Deferred Income Tax | 1526 | 1750 | 1800 | 1515 | 1650 |
| Minority Interest | 9707 | 9432 | 9885 | 10290 | 10714 |
| Other Liabilities, Total | 3587 | 3555 | 3601 | 3714 | 3465 |
| Total Equity | 17807 | 17699 | 18301 | 18998 | 19870 |
| Common Stock | 557 | 558 | 558 | 558 | 558 |
| Retained Earnings (Accumulated Deficit) | 17961 | 17948 | 18376 | 18886 | 19313 |
| Other Equity, Total | -711 | -807 | -633 | -446 | -1 |
| Total Liabilities & Shareholders’ Equity | 68966 | 69655 | 71081 | 71962 | 73114 |
| Total Common Shares Outstanding | 557.542 | 558.041 | 558.454 | 558.502 | 558.502 |
- Jaarlijks
- Per kwartaal
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Netto-inkomen/Beginsaldo | 2676 | 3033 | 3714 | 3029 | 2823 | 2819 |
| Geldmiddelen uit Operationele Activiteiten | 3585 | 3937 | 3742 | 4263 | 6549 | 5078 |
| Geldmiddelen uit Operationele Activiteiten | 982 | 1139 | 1133 | 2085 | 2715 | 2667 |
| Amortization | 233 | 298 | 362 | 327 | ||
| Deferred Taxes | 3 | -230 | 100 | 71 | 43 | 84 |
| Niet-Geldelijke Posten | 2 | -122 | -876 | -67 | -60 | 42 |
| Cash Taxes Paid | 894 | 1187 | 918 | 773 | 765 | 750 |
| Contant Betaalde Rente | 562 | 566 | 519 | 733 | 627 | 517 |
| Veranderingen in het Operationeel Kapitaal | -311 | -181 | -691 | -1182 | 1028 | -534 |
| Geldmiddelen uit Investeringsactiviteiten | -2101 | -7570 | -1464 | -4856 | -3011 | -2817 |
| Kapitaaluitgaven | -1641 | -1823 | -2149 | -2459 | -2406 | -2047 |
| Overige Cash Flow investeringsposten, Totaal | -460 | -5747 | 685 | -2397 | -605 | -770 |
| Geldmiddelen uit Financieringsactiviteiten | -974 | 3872 | -1273 | -484 | -3117 | -1452 |
| Financiering van Cash Flow Posten | 116 | 157 | -290 | 381 | -980 | -601 |
| Total Cash Dividends Paid | -738 | -924 | -904 | -952 | -468 | -491 |
| Uitgifte (Aflossing) van aandelen, netto | 78 | 23 | 55 | -551 | -348 | 38 |
| Uitgifte (Aflossing) van Schulden, Netto | -430 | 4616 | -134 | 638 | -1321 | -398 |
| Wisselkoerseffecten | 25 | -182 | 68 | 22 | -238 | 118 |
| Nettowijziging in Geldmiddelen | 535 | 57 | 1073 | -1055 | 183 | 927 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 671 | 1379 | 2060 | 2819 | 599 |
| Cash From Operating Activities | 652 | 2103 | 3329 | 5078 | 101 |
| Cash From Operating Activities | 622 | 1263 | 1922 | 2667 | 693 |
| Deferred Taxes | -24 | -38 | -34 | 84 | -22 |
| Non-Cash Items | -8 | -4 | -26 | 42 | -11 |
| Cash Taxes Paid | 83 | 428 | 552 | 750 | 87 |
| Cash Interest Paid | 143 | 256 | 377 | 517 | 158 |
| Changes in Working Capital | -609 | -497 | -593 | -534 | -1158 |
| Cash From Investing Activities | -474 | -1429 | -1986 | -2817 | -448 |
| Capital Expenditures | -417 | -924 | -1371 | -2047 | -362 |
| Other Investing Cash Flow Items, Total | -57 | -505 | -615 | -770 | -86 |
| Cash From Financing Activities | -184 | -328 | -895 | -1452 | -375 |
| Financing Cash Flow Items | -50 | -434 | -511 | -601 | 470 |
| Total Cash Dividends Paid | 0 | -491 | -491 | -491 | 0 |
| Issuance (Retirement) of Stock, Net | 1 | 21 | 36 | 38 | 1 |
| Issuance (Retirement) of Debt, Net | -135 | 576 | 71 | -398 | -846 |
| Foreign Exchange Effects | 46 | 67 | 128 | 118 | 35 |
| Net Change in Cash | 40 | 413 | 576 | 927 | -687 |
| Naam investeerder | Type investeerder | Percentage uitstaand | Aandelen in bezit | Wijziging aandelen | Datum bezit | Omzetcijfer |
|---|---|---|---|---|---|---|
| Else Kroner-Fresenius Foundation | Corporation | 26.96 | 151848770 | 0 | 2022-11-23 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.74 | 26697447 | 0 | 2022-11-23 | LOW |
| Harris Associates L.P. | Investment Advisor/Hedge Fund | 3.02 | 17009766 | 0 | 2022-07-07 | LOW |
| Allianz Global Investors GmbH | Investment Advisor | 2.98 | 16784471 | 189035 | 2022-07-07 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.1356 | 12028619 | 33229 | 2022-12-31 | LOW |
| Amundi Asset Management, SAS | Investment Advisor/Hedge Fund | 2.11 | 11884186 | 533930 | 2022-12-31 | HIGH |
| DWS Investment GmbH | Investment Advisor/Hedge Fund | 1.5399 | 8673403 | 314431 | 2022-12-31 | LOW |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.5039 | 8470403 | -755472 | 2022-12-31 | LOW |
| Franklin Mutual Advisers, LLC | Investment Advisor/Hedge Fund | 1.1631 | 6551075 | 4448 | 2022-12-31 | LOW |
| T. Rowe Price Associates, Inc. | Investment Advisor | 1.1567 | 6514879 | -11045 | 2022-12-31 | LOW |
| Deka Investment GmbH | Investment Advisor/Hedge Fund | 0.6428 | 3620496 | 115247 | 2022-12-31 | LOW |
| BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 0.5374 | 3026773 | -22435 | 2022-12-31 | LOW |
| Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.5309 | 2990424 | 27106 | 2022-12-31 | LOW |
| Schroder Investment Management Ltd. (SIM) | Investment Advisor/Hedge Fund | 0.5187 | 2921254 | -45468 | 2022-12-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.4935 | 2779757 | 0 | 2023-01-31 | LOW |
| BlackRock Asset Management Deutschland AG | Investment Advisor | 0.4468 | 2516717 | -24863 | 2022-12-31 | LOW |
| Caixabank Asset Management SGIIC, S.A.U. | Investment Advisor | 0.4093 | 2305529 | 0 | 2022-11-30 | MED |
| Tweedy, Browne Company LLC | Investment Advisor | 0.4039 | 2275130 | -652500 | 2022-09-30 | LOW |
| Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 0.3902 | 2197748 | -22543 | 2022-12-31 | LOW |
| Swedbank Robur Fonder AB | Investment Advisor/Hedge Fund | 0.3775 | 2126132 | -6968 | 2022-12-31 | LOW |
Waarom Capital.com? De cijfers spreken voor zichzelf.
Capital.com Group +485000+
Handelaren
65000+
Actieve klanten per maand
$48000000+
Maandelijks beleggingsvolume
$28000000+
Probeer het nu Opgenomen per maand
Handelscalculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Handelscommissie
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Hefboom
20:1
- 20
- 100
- 500
- 1000
- 10000
Investering
Positiegrootte (hefboomwerking x investering):
Openingskoers
Slotkoers
Short Long
Fresenius SE & Co Company profile
Over Fresenius SE & Co KGaA
Fresenius SE & Co KGaA is een in Duitsland gevestigde groep in de gezondheidszorg. Het is actief via vier bedrijfssegmenten. Fresenius Medical Care exploiteert een wereldwijd netwerk van dialyseklinieken voor de behandeling van patiënten met chronisch nierfalen. Het biedt ook dialysatoren, dialysemachines en farmaceutische producten voor nieren aan. Fresenius Kabi is gespecialiseerd in intraveneus toegediende generieke geneesmiddelen (IV-geneesmiddelen), klinische voeding en infuustherapieën. Het levert ook medische apparatuur en producten van de transfusietechnologie aan ziekenhuizen. Fresenius Helios is een privé-ziekenhuisexploitant met meer dan 130 faciliteiten in Duitsland, waaronder ziekenhuizen voor maximale verzorging en revalidatiecentra en, via Quironsalud, meer dan 80 ziekenhuizen en poliklinische centra, evenals ongeveer 300 centra voor risicopreventie op het werk in Spanje. Fresenius Vamed beheert projecten en levert diensten voor zorgfaciliteiten over de hele wereld, van ontwikkeling en sleutelklare bouw tot onderhoud en totaal operationeel beheer.
| Industry: | Hospitals, Clinics & Primary Care Services |
Else-Kröner-Str. 1
BAD HOMBURG VOR DER HOHE
HESSEN 61352
DE
Winst- en verliesrekening
- Annual
- Quarterly
Mensen bekijken ook
Nog steeds op zoek naar een broker die u kunt vertrouwen?
Sluit u aan bij de 485.000+ handelaren die er wereldwijd voor kozen om met Capital.com te handelen